Neutra Corp (OTCMKTS:NTRR) Terminates Reverse Stock Split Amid Tremendous Progress in 2019

Neutra Corp (OTCMKTS:NTRR) has announced the termination of reverse stock split amid achieving tremendous progress in 2019 toward reaching the long term goals. To become a vertically integrated firm to compete in the cannabidiol market, it will concentrate on the acquisition for which discussions are underway.

Shareholders to benefit

Sydney Jim, Chief Executive Officer of Neutra, said the company hired the services of a well-known physician to help in entering the medicine and sports nutrition markets. Neutra has recently completed the takeover of VIVIS Corp, a respected and prominent retail firm. VIVIS is gearing up to unveil hemp-based and transdermal sports cream aimed at athletes and others looking for immediate relief after engaging in performances and tough workouts.

Jim said the company is benefiting from the services of a dedicated sports medicine advisor, who is hired in early 2019. It aims to develop CBD products, which are derived from hemp, to meet the demand of the growing sports market. The upcoming transdermal cream from VIVIS would help Americans, who are eagerly waiting to get relief from pain and aches, and boost their performance, and get protection from injuries. It helps Americans to lead a healthy lifestyle. Neutra will subject the transdermal cream of VIVIS to third-party verification to ensure that it is free from contaminants and maintains potency and consistency.

Several acquisitions now in the offing, and thanks to the tremendous progress achieved so far in 2019, Neutra terminated the reverse stock split for the benefit of shareholders and the company.

Sales of CBD supplements and remedies

The sales of supplements and medications that comprise CBD as the key ingredient are estimated at $51.2 million, an increase of 332.8% in 2018 when compared to 2017. According to industry watchers, the market for CBD would reach $11 billion by the year 2026.

Cannabidiol (CBD), which is derived from hemp, offers a lot of wellness and health benefits. According to the user testaments, CBD helps to reduce pain and slows down neurodegenerative disorders. It also helps to reduce the effects of seizures and the side effects of specific cancer treatments. CBD is legal and has no psychoactive effect.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.

Leave a Reply

Your email address will not be published. Required fields are marked *

Pin It on Pinterest